Cerus Inc (CERS): Earnings per share for the last twelve months

Brandmark of Cerus Corp. (CERS)

The slow adoption of costly blood purification systems and insurance risks are constraining revenue for Cerus Corporation (CERS). The change in the rolling annual EPS visualizes these barriers, where the -0.04 mark indicates the current yield level. Stability is supported by the global authority of Intercept technologies and the humanitarian status of the business, which remains virtually unaffected by global trade conflicts.

CERS cerus.com Net earnings per share for the last four quarters (07/04/2022 - 11/17/2026)

Analytical breakdowns for Cerus Corporation (CERS)

- stock price and consensus target price:
- stock exchange capitalization data:
Analysis of all company metrics:CERS - Cerus Corp.
Mass-produced product of Cerus Inc

TTM net income per share measures the business's specific annual profitability, excluding the impact of issuance volume and accounting for operating expenses. By analyzing the TTM net income per share of Cerus Corporation (CERS), an investor identifies sustainable profit price ranges, which for Cerus Corporation depend directly on global demand for donor blood sterilization technologies within INTERCEPT systems.

Competitor analysis

Intuitive Surgical, Inc. - Net earnings per share (EPS TTM)|DHR (Danaher Corporation) - Earnings per share for the last 12 months|Becton Dickinson & Company (BDX) - Earnings per share for the last twelve months|STE - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months WST|BAX (baxter.com) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months MASI (Masimo Corporation)|Earnings per share for the last four quarters STVN|Teleflex Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|Dentsply Sirona Inc (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months LeMaitre Vascular|ATRC (atricure.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co STAA|Earnings per share for the last twelve months ChromaDex (NAGE)|ZimVie - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters TKNO (Alpha Teknova)|MGRM - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Sharps Technology STSS|INFU: Net earnings per share (EPS TTM)|Utah Medical Products, Inc. (UTMD) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KORU Medical Systems, Inc.|Net earnings per one share for the last twelve months Nyxoah, S.A. NYXH|Net earnings per share (EPS TTM) MBOT|PDEX - Net earnings per one share for the last twelve months|Zentek Limited - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ELUT (Elutia Inc.)|MLSS - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months NEXGEL Inc.|RVP (retractable.com) - Net earnings per share for the last 12 months|Harvard Bioscience, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months femasys.com|Net earnings per share for the last 12 months MeihuaMed (MHUA)|Net earnings per share (EPS TTM) POAI|Earnings per share for the last four quarters CJMB|Earnings per share for the last twelve months atrioncorp.com ATRI|Earnings per share for the trailing year NURO